Press Releases -> Pharmaceuticals & Biotech Syndicate content

Jul 14, 2019

Kenneth Lee envisions a 'biofarming' future for Hong Kong

CUHK embryologist Kenneth Lee is working to manufacture living tissue in the lab. That shows great promise for developing human organ patches that could be used to repair the body.

There’s another important use for manufactured tissue: we can...

Jul 11, 2019

SINGAPORE, July 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in...

Jul 10, 2019

TOKYO--(BUSINESS WIRE)--Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received self-affirmed GRAS (Generally Recognized as Safe) for infant formulas, in honor of its 50th anniversary.

...
Jul 07, 2019

Strives to Change the Cancer Treatment Model in Hong Kong
Ready to Tap Tremendous Opportunities in Greater Bay Are

Jun 17, 2019

Beijing, 17 June 2019 --( ASIA TODAY )-- Reed Sinopharm Exhibitions (RSE) is delighted to share key highlights from its Personal Care and Homecare Ingredients (PCHi) 2019 post-show report.

Jun 03, 2019

FANGCHENGGANG, China, June 3, 2019 /PRNewswire/ -- As reported by CRI Online: Recently, the International Medical Innovation and Cooperation Forum (China-Shanghai Cooperation Organization), co-sponsored by the Shanghai Cooperation Organization Good-Neighborly Friendship and Cooperation Committee and the People's...

Jun 03, 2019

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early bactericidal activity) clinical trial for telacebec (Q203), a first-in-class, orally-available antibiotic for the treatment of tuberculosis (TB). Telacebec is a selective inhibitor with high...

May 30, 2019

Promoting precision medicine business with in-house assets and collaboration with external venture partner

May 28, 2019

Partnership accelerates access to inebilizumab in China and supports the mission of both companies to bring transformative therapies to more patients around the world

Viela Bio is eligible to receive an upfront collaboration fee and milestone payments of more than $220 million plus royalties on product sales...

May 23, 2019

Singapore, 23 May 2019 --( ASIA TODAY )-- Singapore-based researchers have discovered a possible solution to impede the evolution of bacteria into superbugs that are resistant to drugs and therefore harder to kill. Building on a decade’s work on antimicrobial technologies, the multidisciplinary team from Institute...

May 21, 2019

Data Supports Continued Dose Escalation and Further Investigation in Metastatic Renal Cell Carcinoma (mRCC)

May 16, 2019

HUDSON, Wis.--(BUSINESS WIRE)--Phillips-Medisize, a Molex company, will have a major exhibiting and speaking presence at the 8th Annual InnoPack Pharma Confex, to be held May 21 – 22 in Mumbai. As an established global leader, Phillips-Medisize provides a wide range of custom drug delivery devices, connected health...

May 13, 2019

Himalaya Drug Company to launch new state-of-the-art Global Research Centre in Dubai

Apr 17, 2019

HONG KONG, April 17, 2019 /PRNewswire/ -- Cosmoprof Asia, the leading b2b international beauty trade show in Asia, turns 24 this November. The success of the "One Fair, Two Venues" formula is well reflected in the results of the last edition: 5% growth in number of exhibitors to 3,030 companies from 53 countries...

Apr 10, 2019

April 10, 2019 08:00 PM Hong Kong Time - AMSTERDAM--(BUSINESS WIRE)--Synaffix B.V., a Dutch biotechnology company exclusively focused on continued advancement of its clinical-stage antibody-drug conjugate (ADC) technology for the development of best-in-class ADCs, announces that it has entered into a license...

Apr 02, 2019

April 02, 2019 04:00 PM Hong Kong Time - GARCHING/MUNICH, Germany & SHANGHAI--(BUSINESS WIRE)--ITM Isotopen Technologien München AG (ITM), a group of specialized radiopharmaceutical companies and United Imaging Healthcare Co., Ltd. (UIH), a leader in next generation precision cancer imaging and innovative...

Mar 29, 2019

GUANGZHOU, China, March 28, 2019 /PRNewswire/ -- Online pre-registration is now open for the 28th China (Guangzhou) International Health Industry Expo (IHE China) - China's authoritative B2B fair for the health industry. From 26 – 28 June 2019, IHE China will be held at China Import and Export Fair Complex,...

Mar 22, 2019

– Takeda obtains rights to LCB’s ADC platform for multiple targets –

March 22, 2019 01:40 PM Hong Kong Time - DAEJEON, South Korea--(BUSINESS WIRE)--LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080) announced today that it has entered a research collaboration and license agreement with Takeda Pharmaceutical...

Mar 20, 2019

March 20, 2019 11:40 PM Hong Kong Time - SHANGHAI--(BUSINESS WIRE)--To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center for Gene and Cell Therapy. Miltenyi is a global leader in the design, development, manufacturing, and integration...

Mar 18, 2019

March 18, 2019 08:00 PM Hong Kong Time - OSAKA, Japan & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that the companies have...

Mar 04, 2019

New clinical data and case studies highlight the use of DiaResQ in a range of real world settings, from hospitals to disaster relief, in its first annual scientific meeting

Mar 04, 2019

March 05, 2019 12:26 AM Hong Kong Time - HONG KONG--(BUSINESS WIRE)--Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today...